Michelson enters OCT reseller agreement with Biotronics3D

Michelson Diagnostics, a developer of multi-beam optical coherence tomography (OCT) products, has entered into a reseller agreement with London-based Biotronics3D, a developer of software applications for the diagnostic imaging industry.

Under the terms of the agreement, Michelson of Orpington, England, will market and sell Biotronics’ 3Dnet Suite with its VivoSight Scanner and EX1301 OCT Microscope.

According to Michelson, Biotronics’ 3Dnet Suite is an FDA-cleared medical imaging display tool with capabilities to view and analyze 3D DICOM datasets. It is used by clinicians to examine CT, MRI and ultrasound images, and can segment and display renderings of 3D structures from low-contrast image sets. It also can output reports in user-defined formats and can export to PACS, and provides 3D measurement and image annotation tools.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”